Low Vitamin D Status Is Associated with Nonalcoholic Fatty Liver Disease Independent of Visceral Obesity in Korean Adults

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Seo, Ji A ^a   Eun, Chai Ryoung ^a   Cho, Hyunjoo ^a   Lee, Seung Ku ^a   Yoo, Hye Jin ^a   Kim, Sin Gon ^a   Choi, Kyung Mook ^a   Baik, Sei Hyun ^a   Choi, Dong Seop ^a   Yim, Hyung Joon ^a   Shin, Chol ^a   Kim, Nan Hee ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANTHROPOMETRY; ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; ETHNIC GROUP; EXERCISE; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KOREAN; LIVER ATTENUATION INDEX; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; POPULATION RESEARCH; RATING SCALE; SEASON; SEX; VISCERAL OBESITY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84885162128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075197     Document Type: Article

References (52)

1. Choi HS, Kim KA, Lim CY, Rhee SY, Hwang YC, et al. (2011) Low serum vitamin d is associated with high risk of diabetes in korean adults. J Nutr 141: 1524-1528.
2. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, et al. (2010) Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 51: 1979-1987.
3. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168: 1609-1616.
4. Fisher L, Fisher A, (2007) Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 5: 513-520.
5. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, et al. (2010) Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 51: 1158-1167.
6. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, et al. (2007) Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17: 517-524.
7. Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, et al. (2011) Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 55: 415-425.
8. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ, (2008) Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57: 2619-2625.
9. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, et al. (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89: 1196-1199.
10. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Al-Othman A, et al. (2011) Hypovitaminosis D Associations with Adverse Metabolic Parameters Are Accentuated in Patients with Diabetes Mellitus Type 2: A BMI-Independent Role of Adiponectin? J Endocrinol Invest 36: 1-6.
11. Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, et al. (2011) Vitamin D deficiency in obese rats exacerbates NAFLD and increases hepatic resistin and toll-like receptor activation. Hepatology 55: 1103-1111.
12. George PS, Pearson ER, Witham MD, (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 29: e142-150.
13. Shin C, Kim J, Lee S, Shim J, In K, et al. (2005) Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 171: 287-291.
14. Baik I, Kim J, Abbott RD, Joo S, Jung K, et al. (2008) Association of snoring with chronic bronchitis. Arch Intern Med 168: 167-173.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
16. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, et al. (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230: 276-280.
17. Hubscher SG, (2006) Histological assessment of non-alcoholic fatty liver disease. Histopathology 49: 450-465.
18. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, et al. (2003) Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26: 3320-3325.
19. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, et al. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349.
20. Barchetta I, Angelico F, Ben MD, Baroni MG, Pozzilli P, et al. (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9: 85.
21. Rhee EJ, Kim MK, Park SE, Park CY, Baek KH, et al. (2013) High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J. In press.
22. Gascon-Barre M, Demers C, Mirshahi A, Neron S, Zalzal S, et al. (2003) The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 37: 1034-1042.
23. Valdivielso JM, Fernandez E, (2006) Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 371: 1-12.
24. Vogel A, Strassburg CP, Manns MP, (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35: 126-131.
25. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, et al. (2010) Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 59: 242-248.
26. Samuel VT, Shulman GI, (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
27. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, et al. (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109: 1345-1350.
28. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, et al. (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106: 15430-15435.
29. Fabbrini E, Tamboli RA, Magkos F, Marks-Shulman PA, Eckhauser AW, et al. (2010) Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 139: 448-455.
30. Beydoun MA, Boueiz A, Shroff MR, Beydoun HA, Wang Y, et al. (2010) Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 95: 3814-3827.
31. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, et al. (2011) Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 94: 209-217.
32. Pinelli NR, Jaber LA, Brown MB, Herman WH, (2010) Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 33: 1373-1375.
33. Scragg R, Sowers M, Bell C, (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2813-2818.
34. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, et al. (2009) Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139: 329-334.
35. Nagpal J, Pande JN, Bhartia A, (2009) A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26: 19-27.
36. von Hurst PR, Stonehouse W, Coad J, (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient- a randomised, placebo-controlled trial. Br J Nutr 103: 549-555.
37. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, et al. (1997) No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 27: 629-633.
38. Gannage-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, et al. (2003) Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 26: 748-753.
39. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, et al. (2006) Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 21: 695-700.
40. Park SH, Lee WY, Rhee EJ, Jeon WK, Kim BI, et al. (2005) Relative risks of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults. Clin Sci (Lond) 108: 553-559.
41. Bhatnagar S, Damron HA, Hillgartner FB, (2009) Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem 284: 10023-10033.
42. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, et al. (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145: 2594-2603.
43. Tomlinson E, Fu L, John L, Hultgren B, Huang X, et al. (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143: 1741-1747.
44. Schmidt DR, Holmstrom SR, Fon Tacer K, Bookout AL, Kliewer SA, et al. (2010) Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem. 285: 14486-14494.
45. Schreuder TC, Marsman HA, Lenicek M, van WervenJR, Nederveen AJ, et al. (2010) The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol 298: G440-445.
46. Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, et al. (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr. In press.
47. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, et al. (2003) The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35: 807-825.
48. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
49. Adachi M, Brenner DA, (2008) High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology 47: 677-685.
50. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
51. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
52. Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, et al. (2012) Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 22: 1075-1082.